Prevalence of acromegaly in patients with symptoms of sleep apnea

Autor: Sesmilo, Gemma, Resmini, Eugenia, Sambo, Marcel, Blanco, Concepción, Calvo, Fernando, Pazos, Fernando, Fernández-Catalina, Pablo, Martínez de Icaya, Purificación, Páramo, Concepción, Fajardo, Carmen, Marazuela Azpiroz, Mónica, Álvarez Escolá, María Cristina, Díez Gómez, Juan José, Perea, Verónica, ACROSAHS study group
Přispěvatelé: UAM. Departamento de Medicina, Instituto de Investigación del Hospital de La Princesa (IP)
Rok vydání: 2017
Předmět:
Male
Pediatrics
Pulmonology
Apnea
Peptide Hormones
lcsh:Medicine
Biochemistry
Nervous System
Diagnostic Radiology
0302 clinical medicine
Endocrinology
Epidemiology
Medicine and Health Sciences
Prevalence
030212 general & internal medicine
Insulin-Like Growth Factor I
lcsh:Science
Multidisciplinary
medicine.diagnostic_test
Radiology and Imaging
Sleep apnea
Middle Aged
Magnetic Resonance Imaging
medicine.anatomical_structure
Neurology
Pituitary Gland
Female
Anatomy
Research Article
Adult
medicine.medical_specialty
Sleep Apnea
Patients
Endocrine Disorders
Imaging Techniques
Medicina
030209 endocrinology & metabolism
Endocrine System
Research and Analysis Methods
03 medical and health sciences
Sleep Apnea Syndromes
Tongue
Diagnostic Medicine
Diabetes mellitus
Acromegaly
medicine
Diabetes Mellitus
Humans
sleep apnea symptom
Carpal tunnel syndrome
Aged
Mouth
Health Care Policy
business.industry
lcsh:R
Biology and Life Sciences
Magnetic resonance imaging
medicine.disease
Hormones
Health Care
Neuroanatomy
Spain
Growth Hormone
Metabolic Disorders
Symptoms
lcsh:Q
business
Sleep Disorders
Digestive System
Biomarkers
Screening Guidelines
Rare disease
Neuroscience
Zdroj: Biblos-e Archivo. Repositorio Institucional de la UAM
instname
PLoS One
r-FISABIO. Repositorio Institucional de Producción Científica
PLoS ONE
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS ONE, Vol 12, Iss 9, p e0183539 (2017)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
ISSN: 1932-6203
Popis: Acromegaly is a rare disease with nonspecific symptoms with acral enlargement being almost universally present at diagnosis. The estimated prevalence is 40–125 cases/million but targeted universal screening studies have found a higher prevalence (about 10 fold). The aim of the ACROSAHS study was to investigate the prevalence of acromegaly and acromegaly comorbidities in patients with sleep apnea symptoms and acral enlargement. ACROSAHS was a Spanish prospective non-interventional epidemiological study in 13 Hospital sleep referral units. Facial and acral enlargement symptoms including: ring size and shoe size increase, tongue, lips and jaws enlargement, paresthesia or carpal tunnel syndrome and widening of tooth spaces, as well as other typical acromegaly comorbidities were recorded with a self-administered questionnaire of patients who attended a first visit for sleep apnea symptoms between 09/2013 and 07/2014. Serum insulin-like growth factor type 1 (IGF1) was measured in patients with ≥1 acral symptom to determine the prevalence of acromegaly. Of the 1557 patients enrolled, 1477 with complete data (72% male) were analyzed. 530 patients (36%) reported at least 1 acral enlargement symptom and were tested for IGF-1, 41 were above range, persisted in 7, and among those, 2 cases of acromegaly were diagnosed (prevalence of at least 1.35 cases/1000). Overall, 1019 patients (69%) had ≥2 acromegaly symptoms and should have been screened according to guidelines; moreover 373 patients (25%) had ≥1 symptom of acral enlargement plus ≥3 other acromegaly symptoms. In conclusion, in patients with sleep apnea symptoms and acral enlargement, we found an acromegaly prevalence of at least 1.35 cases per 1000 and a high prevalence of typical acromegaly symptoms. It is important that sleep specialists are aware of acromegaly symptoms to aid with acromegaly diagnosis.
The study was investigator initiated and was partially sponsored by Ipsen Pharma, S.A., Spain
Databáze: OpenAIRE